Chronic mild hypoxia ameliorates chronic inflammatory activity in myelin oligodendrocyte glycoprotein (MOG) peptide induced experimental autoimmune encephalomyelitis (EAE)

Advances in Experimental Medicine and Biology

Volumn 701, Issue , 2011, Pages 165-173

  Dore Duffy, Paula ^a   Wencel, Marie ^a   Katyshev, Vladimir ^a   Cleary, Kristen ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MYELIN OLIGODENDROCYTE GLYCOPROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CAPILLARY DENSITY; CLINICAL FEATURE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HYPOXIA; IMMUNOCYTOCHEMISTRY; METABOLIC REGULATION; MOUSE; NEUROPROTECTION; NONHUMAN; OXYGEN TENSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; THERAPY EFFECT; TISSUE REPAIR;

EID: 84934439691     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-7756-4_23     Document Type: Conference Paper

References (34)

1. Hawkins BT, Davis TP (2005) The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev 57:173-85. (Pubitemid 41043883)
2. Chávez JC, Agani F, Pichiule P, et al. (2000) Expression of hypoxia-inducible factor-1alpha in the brain of rats during chronic hypoxia. J Appl Physiol 89:1937-42.
3. Xu K, Lamanna JC (2006) Chronic hypoxia and the cerebral circulation. J Appl Phys 100:725-30. (Pubitemid 43671631)
4. Dore-Duffy P, LaManna JC (2007) Physiologic angiodynamics in the brain. Antioxid Redox Signal 9:1363-71. (Pubitemid 47255015)
5. Charcot JM(1868)Histologie de la sclérose en plaques.Gazette desHôpitaux civils etmilitaires 41: 554, 557-558, 566.
6. Sospedra M, Martin R (2005) Immunology of multiple sclerosis. Annu Rev Immuno 23:683-747. (Pubitemid 40563183)
7. Barnett MH, Sutton I (2006) The pathology of multiple sclerosis: A paradigm shift. Curr Opin Neurol 19:242-7. (Pubitemid 43804677)
8. Franklin RJ (2002) Why does remyelination fail inmultiple sclerosis? Nat Rev Neurosci 3:705-14. (Pubitemid 135706676)
9. Trapp BD, Stys PK (2009) Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis. Lancet Neurol 8:280-91.
10. LaManna JC, Chavez JC, Pichiule P (2004) Structural and functional adaptation to hypoxia in the rat brain. J Exp Biol 207:3163-9. (Pubitemid 39275291)
11. Puchowicz MA, Koppaka SS, LaManna JC (2009) Brain metabolic adaptations to hypoxia. In: McCandless DW (ed) Metabolic Encephalopathy, Springer, US.
12. Henry TD (1999) Therapeutic angiogenesis. BMJ 318:1536-9. (Pubitemid 29255800)
13. Ye L, Haider HK, Jiang SJ, et al. (2004) Therapeutic angiogenesis using vascular endothelial growth factor. Asian Cardiovasc Thorac Ann 12:173-81. (Pubitemid 39010984)
14. Waltenberger J (1998) Therapeutic angiogenesis in the heart using peptide growth factors: Angiogenesis research entering clinical trials. Angiogenesis 2:115-117. (Pubitemid 128511978)
15. Ylä-Herttuala S, Rissanen TT, Vajanto I, et al. (2007) Vascular endothelial growth factors: Biology and current status of clinical applications in cardiovascularmedicine. JAmCollCardiol 49:1015-26. (Pubitemid 46349500)
16. Bouïs D, Kusumanto Y, Meijer C, et al. (2006) A review on pro- and anti-angiogenic factors as targets of clinical intervention. Pharmacol Res 53:89-103. (Pubitemid 43003475)
17. Santulli G, Ciccarelli M, Palumbo G, et al. (2009) In vivo properties of the proangiogenic peptide QK. J Transl Med 7:41.
18. Humar R, Zimmerli L, Battegay E (2009) Angiogenesis and hypertension: An update. J Hum Hypertens. doi: 10.1038/jhh.2009.63.
19. Benarroch EE (2009) Hypoxia-inducedmediators and neurologic disease. Neurology 73:560-5.
20. Serebrovskaya TV, Manukhina EB, Smith ML, et al. (2008) Intermittent hypoxia: Cause of or therapy for systemic hypertension? Exp Biol Med (Maywood) 233:627-50.
21. Gustafsson T, Puntschart A, Kaijser L, et al. (1999) Exercise-induced expression of angiogenesis-related transcription and growth factors in human skeletal muscle. Am J Physiol 276:H679-85. (Pubitemid 29100638)
22. Ding Y, Li J, Luan X, et al.(2004) Exercise pre-conditioning reduces brain damage in ischemic rats that may be associated with regional angiogenesis and cellular overexpression of neurotrophin. Neuroscience 124:583-91. (Pubitemid 38251326)
23. Ding YH, Ding Y, Li J, et al. (2006) Exercise pre-conditioning strengthens brain microvascular integrity in a rat stroke model. Neurol Res 28:184-9.
24. Kreipke CW, Morgan R, Kallakuri S, et al. (2007) Behavioral pre-conditioning enhances angiogenesis and cognitive outcome after brain trauma. Neurol Res 29:388-94. (Pubitemid 47196058)
25. Schroedl C, McClintock DS, Budinger GR, et al. (2002) Hypoxic but not anoxic stabilization of HIF-1alpha requires mitochondrial reactive oxygen species. Am J Physiol Lung Cell Mol Physiol 283:L922-31. (Pubitemid 35204884)
26. Post DE, Van Meir EG (2001) Generation of bidirectional hypoxia/HIF-responsive expression vectors to target gene expression to hypoxic cells. Gene Ther 8:1801-7. (Pubitemid 34100581)
27. Grimm C, Wenzel A, Stanescu D, et al. (2004) Constitutive overexpression of human erythropoietin protects the mouse retina against induced but not inherited retinal degeneration. J Neurosci 24:5651-8. (Pubitemid 38857219)
28. Grimm C, Hermann DM, Bogdanova A, et al. (2005) Neuroprotection by hypoxic preconditioning: HIF-1 and erythropoietin protect from retinal degeneration. Semin Cell Dev Biol 16:531-8. (Pubitemid 41247876)
29. Anderson J, Sandhir R, Hamilton ES, et al. (2009) Impaired Expression of Neuroprotective Molecules in the HIF-1-alpha Pathway following Traumatic Brain Injury inAgedMice. Journal of Neurotrauma. doi:10.1089/neu.2008-0765
30. Harten SK, Ashcroft M, Maxwell PH (2009) Prolyl Hydroxlase Domain (PHD) inhibitors: A route to HIF activation & neuroprotection. Antioxidants & Redox Signaling. doi:10.1089/ars.2009.2870.
31. Dore-Duffy P, Washington R, Dragovic L (1993) Expression of endothelial cell activation antigens in microvessels from patients with multiple sclerosis. Adv Exp Med Biol 331:243-8. (Pubitemid 23180918)
32. Dore-Duffy P, Balabanov R, Rafols J, et al. (1996) Recovery phase of acute experimental autoimmune encephalomyelitis in rats corresponds to development of endothelial cell unresponsiveness to interferon gamma activation. J Neurosci Res 44:223-34. (Pubitemid 26134412)
33. Dore-Duffy P, Balabanov R, Beaumont T, et al. (1999) Endothelial activation following prolonged hypobaric hypoxia. Microvasc Res 57:75-85. (Pubitemid 29393284)
34. Milner R, Hung S, Erokwu B, et al. (2008) Increased expression of fibronectin and the alpha 5 beta 1 integrin in angiogenic cerebral blood vessels of mice subject to hypobaric hypoxia. Mol Cell Neurosci 38:43-52.